Brief: Titan Pharmaceuticals Inc - On March 16, Got Letter From NASDAQ It Is No Longer In Compliance With Minimum Bid Price Requirement
22/03/2023 20:21
March 22 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS INC - ON MARCH 16, GOT LETTER FROM
NASDAQ
THAT IT IS NO LONGER IN COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.